Oral Administration of Lipopolysaccharide Enhances Insulin Signaling-Related Factors in the KK/Ay Mouse Model of Type 2 Diabetes Mellitus

Lipopolysaccharide (LPS), an endotoxin, induces systemic inflammation by injection and is thought to be a causative agent of chronic inflammatory diseases, including type 2 diabetes mellitus (T2DM). However, our previous studies found that oral LPS administration does not exacerbate T2DM conditions...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Kazushi, Yamashita, Masashi, Oda, Masataka, Tjendana Tjhin, Vindy, Inagawa, Hiroyuki, Soma, Gen-Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003108/
https://www.ncbi.nlm.nih.gov/pubmed/36902049
http://dx.doi.org/10.3390/ijms24054619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003108/
https://www.ncbi.nlm.nih.gov/pubmed/36902049
http://dx.doi.org/10.3390/ijms24054619

Ejemplares similares